Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.

 
Web www.patentalert.com

< Methods of treatment using antibodies to follistatin-3

> Polynucleotides encoding soluble zalpha11 cytokine receptors

> Methods and compositions for regenerating tissue
~ 00546